A narrative review of the health disparities associated with malignant pleural mesothelioma

被引:7
|
作者
Freudenberger, Devon C. [1 ]
Shah, Rachit D. [1 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Div Cardiothorac Surg, Richmond, VA 23284 USA
关键词
Malignant pleural mesothelioma (MPM); health disparities; SURVIVAL; EPIDEMIOLOGY; DISEASE; TRENDS; CARE;
D O I
10.21037/jtd-20-3516
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Malignant pleural mesothelioma (MPM) is a cancer of the mesothelial lining of the pleura that has traditionally been associated with asbestos exposure in an industrial setting. Asbestos usage has fortunately been banned or phased out in most industrialized countries resulting in its decline in countries such as the United States. Despite this, MPM continues to place significant burden on its affected patients resulting in overall poor prognosis and survival. Questions arise as to what factors, especially what health disparities, contribute to the disease's dismal prognosis. This article will present a narrative review of recent literature that identifies the impact age, sex, race, access to medical centers, and economics have on the diagnosis, treatment, and prognosis of MPM. As will be discussed, research has shown that factors including younger age, female sex, non-white race, private insurance, Medicare, and higher income have been associated with better survival in MPM. Whereas older age, male sex, white race, lack of insurance, and lower income are associated with worse survival. The identification of these and other health disparities related to MPM may allow for future research, clinical guidelines, and policies to be implemented to decrease the burden health disparities create in the diagnosis, treatment, and prognosis of patients with MPM.
引用
收藏
页码:3809 / 3815
页数:7
相关论文
共 50 条
  • [41] Malignant Pleural Mesothelioma
    Raja, Siva
    Murthy, Sudish C.
    Mason, David P.
    CURRENT ONCOLOGY REPORTS, 2011, 13 (04) : 259 - 264
  • [42] Pleural malignant mesothelioma
    不详
    RADIOGRAPHICS, 1996, 16 (03) : 612 - 612
  • [43] Malignant pleural mesothelioma
    Margery, J.
    Planchard, D.
    ONCOLOGIE, 2014, 16 (05) : 245 - 249
  • [44] Malignant pleural mesothelioma
    Rao, Sukhesh
    LUNG INDIA, 2009, 26 (02) : 53 - 54
  • [45] Malignant pleural mesothelioma
    Ploenes, T.
    Osei-Agyemang, T.
    Nestle, U.
    Waller, C. F.
    Passlick, B.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (10) : 481 - 486
  • [46] Malignant pleural mesothelioma
    Kindler H.L.
    Current Treatment Options in Oncology, 2000, 1 (4) : 313 - 326
  • [47] Tumour-Associated MDSC in Malignant Pleural Mesothelioma
    Al-Taei, S.
    Lester, J. F.
    Mason, M. D.
    Tabi, Z.
    IMMUNOLOGY, 2012, 137 : 622 - 622
  • [48] Erionite-associated malignant pleural mesothelioma in Mexico
    Oczypok, Elizabeth A.
    Sanchez, Matthew S.
    Van Orden, Drew R.
    Berry, Gerald J.
    Pourtabib, Kristina
    Gunter, Mickey E.
    Roggli, Victor L.
    Kraynie, Alyssa M.
    Oury, Tim D.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (05): : 5722 - 5732
  • [49] Malignant pleural mesothelioma in 2008. Is there really a future for malignant pleural mesothelioma?
    Doddoli, C.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2008, 64 : 41 - 43
  • [50] Genomic events associated with progression of pleural malignant mesothelioma
    Ivanov, Sergey V.
    Miller, Jeremy
    Lucito, Robert
    Tang, Chunlao
    Ivanova, Alla V.
    Pei, Jianming
    Carbone, Michele
    Cruz, Christina
    Beck, Amanda
    Webb, Craig
    Nonaka, Daisuke
    Testa, Joseph R.
    Pass, Harvey I.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) : 589 - 599